0001144204-14-009003.txt : 20140214
0001144204-14-009003.hdr.sgml : 20140214
20140214093037
ACCESSION NUMBER: 0001144204-14-009003
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20131231
FILED AS OF DATE: 20140214
DATE AS OF CHANGE: 20140214
EFFECTIVENESS DATE: 20140214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foresite Capital Management I, LLC
CENTRAL INDEX KEY: 0001581219
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-15934
FILM NUMBER: 14611171
BUSINESS ADDRESS:
STREET 1: 101 CALIFORNIA STREET, SUITE 4100
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 101 CALIFORNIA STREET, SUITE 4100
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001581219
XXXXXXXX
12-31-2013
12-31-2013
false
Foresite Capital Management I, LLC
101 California Street, Suite 4100
San Francisco
CA
94111
13F HOLDINGS REPORT
028-15934
N
James B. Tananbaum
Managing Member
415-877-4887
/s/ James B. Tananbaum
San Francisco
CA
02-13-2014
0
9
102940
INFORMATION TABLE
2
infotable.xml
ACELRX Pharmaceuticals, Inc.
COM
00444T100
15597
1379080
SH
SOLE
0
0
0
Keryx Biopharmaceuticals Inc.
COM
492515101
16990
1312006
SH
SOLE
0
0
0
Ambit Biosciences Corporation
COM
02318X100
20047
2079569
SH
SOLE
0
0
0
Karyopharm Therapeutics Inc.
COM
48576U106
32620
1585743
SH
SOLE
0
0
0
Acceleron Pharma Inc.
COM
00434H108
2614
66000
SH
SOLE
0
0
0
Novavax Inc.
COM
670002104
6841
1336200
SH
SOLE
0
0
0
Novavax Inc.
COM
670002104
16
6508
SH
Put
SOLE
0
0
0
Xencor, Inc.
COM
98401F105
7495
820000
SH
SOLE
0
0
0
BioDelivery Sciences International, Inc.
COM
09060J106
720
2000
SH
Call
SOLE
0
0
0